Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B LIPTON

Showing results (761-770 of 1,306) with videos related to

Pageof 131
Sort By:
Journal of Patient-Reported Outcomes|April 4, 2023
Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraineJanet H Ford, Wenyu Ye, David W Ayer, et al.
Pain Management|November 19, 2025
Patient-centered outcomes in the acute treatment of migraine: a prospective, real-world, longitudinal survey study (UNIVERSE II) comparing migraine patients who switch from a prior triptan to another triptan or ubrogepantRichard B Lipton, Amit Bodhani, Xingyu Gao, et al.
Headache|July 10, 2024
Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) cross-sectional studyManjit Matharu, Zaza Katsarava, Dawn C Buse, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 13, 2024
"Cognitive" Criteria in Older Adults With Slow Gait Speed: Implications for Motoric Cognitive Risk SyndromeCaroline O Nester, Qi Gao, Cuiling Wang, et al.
Headache|September 1, 1991
Headache in HIV-1-related disordersR B Lipton, E R Feraru, G Weiss, et al.
Headache|September 24, 2019
Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyRichard B Lipton, Susan Hutchinson, Jessica Ailani, et al.
Clinical Therapeutics|November 9, 2004
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)F Michael Cutrer, Peter J Goadsby, Michel D Ferrari, et al.
Cephalalgia : an International Journal of Headache|March 25, 2006
Headache prevention outcome and body mass indexM E Bigal, M Gironda, S J Tepper, et al.
Neurobiology of Aging|November 11, 2008
Contribution of vascular pathology to the clinical expression of dementiaDorothea Strozyk, Dennis W Dickson, Richard B Lipton, et al.
Headache|July 3, 2024
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacksRichard B Lipton, Jessica Ailani, Kathleen Mullin, et al.
Pageof 131

Showing results (761-770 of 1,306) with videos related to

Sort By:
Pageof 131
Journal of Patient-Reported Outcomes|April 4, 2023
Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraineJanet H Ford, Wenyu Ye, David W Ayer, et al.
Pain Management|November 19, 2025
Patient-centered outcomes in the acute treatment of migraine: a prospective, real-world, longitudinal survey study (UNIVERSE II) comparing migraine patients who switch from a prior triptan to another triptan or ubrogepantRichard B Lipton, Amit Bodhani, Xingyu Gao, et al.
Headache|July 10, 2024
Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) cross-sectional studyManjit Matharu, Zaza Katsarava, Dawn C Buse, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 13, 2024
"Cognitive" Criteria in Older Adults With Slow Gait Speed: Implications for Motoric Cognitive Risk SyndromeCaroline O Nester, Qi Gao, Cuiling Wang, et al.
Headache|September 1, 1991
Headache in HIV-1-related disordersR B Lipton, E R Feraru, G Weiss, et al.
Headache|September 24, 2019
Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyRichard B Lipton, Susan Hutchinson, Jessica Ailani, et al.
Clinical Therapeutics|November 9, 2004
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)F Michael Cutrer, Peter J Goadsby, Michel D Ferrari, et al.
Cephalalgia : an International Journal of Headache|March 25, 2006
Headache prevention outcome and body mass indexM E Bigal, M Gironda, S J Tepper, et al.
Neurobiology of Aging|November 11, 2008
Contribution of vascular pathology to the clinical expression of dementiaDorothea Strozyk, Dennis W Dickson, Richard B Lipton, et al.
Headache|July 3, 2024
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacksRichard B Lipton, Jessica Ailani, Kathleen Mullin, et al.
Pageof 131